ClinicalTrials.gg
RecruitingNCT06641336RehAttUpdated Jun 15, 2026

Perceptions of RehAtt Mixed Reality System

An interventional study of RehAtt in Stroke, sponsored by University Rehabilitation Institute, Republic of Slovenia. Recruiting at 1 site in Slovenia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-15.

Sponsored by University Rehabilitation Institute, Republic of Slovenia · Not applicable, Interventional, and Device feasibility

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The study aims to explore the patients' perspective on usability and feasibility of the RehAtt™ mixed-reality system during upper limb, gait and balance function rehabilitation.

Read the detailed description

Mixed reality is an immersive technology that can integrate virtual objects into the real world and adaptive scenarios. It offers the opportunity to train physical and cognitive aspects in stroke patients. The patients' perspectives were assessed with a semi-structured interview.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • rehabilitation
  • mixed reality
  • motor rehabilitation
  • patients' perspective
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 10 is below the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University Rehabilitation Institute, Republic of Slovenia is the lead sponsor of 21 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • first ischaemic or hemorrhagic stroke,
  • one-sided hemiparesis,
  • adequate cognitive abilities.

Exclusion criteria

Exclusion Criteria:

  • severe cognitive impairment,
  • aphasia,
  • known presence of an epileptic seizure in the last year,
  • other orthopaedic and neurological diseases affecting sensory or motor functions,
  • inability to sit independently,
  • severe visual impairment,
  • severe depression.
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    RehAtt

    Each patient was included in the introduction session (performed by a psychologist), three sessions of occupational therapy and three sessions of physiotherapy. Each session lasted for 30 minutes. Occupational-therapy training was focused on activities aimed at improving upper limb function; physiotherapy training was focused on balance, walking and standing.

    Device: RehAtt

Interventions

  • DeviceRehAtt

    Each patient received the RehAtt intervention.

06

What researchers measure

Primary outcomes

  1. Semi-structured interview

    The interview was based on a questionnaire that included rating-scale-based questions on mixed-reality therapy meeting the patient's needs, frustration during the exercise, ease of use, difficulties encountered, motivational aspect, likability and usefulness of each exercise, and open-ended questions on motivation, overall view of the mixed-reality system and possible unwanted effects.

    Time frame: On the day of the end of the intervention

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06641336
Lead sponsor
University Rehabilitation Institute, Republic of Slovenia
Responsible party
Sponsor
First posted
Oct 15, 2024
Start date
Oct 11, 2024
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Jun 15, 2026

Study contacts

Metka Moharić, MD, PhD
Contact
metka.moharic@ir-rs.si
+386 1 4758 441
Nataša Bizovičar, MD, PhD
principal investigator · University Rehabilitation Institute, Republic of Slovenia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion